Add to Favorites Newsroom RSS Share
Aurora, CO USA

Our News on Newswise


Cancer Stem Cells Use “Normal” Genes in Abnormal Ways

University of Colorado Cancer Center study shows that "normal" gene CDK1 interacts with "abnormal" gene Sox2 to keep cancer stem cells "stemmy."
12-Oct-2018 8:05 AM EDT Add to Favorites


Cancer Hijacks the Microbiome to Glut Itself on Glucose

A University of Colorado Cancer Center study published today in the journal Cancer Cell shows that leukemia undercuts the ability of normal cells to consume glucose, thus leaving more glucose available to feed its own growth.
28-Sep-2018 11:05 AM EDT Add to Favorites


Brigatinib becomes potential new first-line option for ALK-positive non-small lung cancer

Results of ALTA-1 trial: Patients given brigatinib saw a statistically significant 51 percent reduction in the risk of progression or death compared with those given crizotinib.
25-Sep-2018 8:05 AM EDT Add to Favorites


Promising Phase 1/2 Results for Entrectinib Against ROS1+ Non-Small Cell Lung Cancer

Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer (NSCLC) presented on the press program of the International Association for the Study of Lung Cancer (IASLC) 19th World Conference on...
24-Sep-2018 8:45 AM EDT Add to Favorites


New Combination Treatment Targets Pre-Leukemia Stem Cells

Omacetaxine (to block protein synthesis) with venetoclax (to block oxidative phosphorylation), was highly effective against CD123+ leukemia stem cells.
12-Sep-2018 1:05 PM EDT Add to Favorites


Like Shark Attack and the Lottery, Unconscious Bias Influences Cancer Screening

Doctors with personal experience of cancer are more likely to act against established guidelines to recommend that low-risk women receive ovarian cancer screening.
17-Aug-2018 12:15 PM EDT Add to Favorites


No single test identifies all ROS1+ lung cancer patients

University of Colorado Cancer Center study shows that common laboratory tests used to determine ROS1 status may return false-negative results, meaning that some patients who could benefit from ROS1-directed therapy may be slipping through the cracks.
8-Aug-2018 11:05 AM EDT Add to Favorites


Ivosidenib earns FDA approval against IDH1+ acute myeloid leukemia

Clinical trials at CU Cancer Center and elsewhere result in FDA approval of the drug ivosidenib for the treatment of adult patients with IDH1+ AML.
30-Jul-2018 10:05 AM EDT Add to Favorites

see all news

Our Experts on Newswise


Will One Bad Sunburn Give You Skin Cancer?

27-Jul-2015 11:05 AM EDT


Oncologists: How to Talk With Your Pathologist About Cancer Molecular Testing

An education session presented today at the American Society for Clinical Oncology (ASCO) Annual Meeting 2014 details the challenges of collaboration between oncologists and pathologists in the context of molecular testing patient tumor samples.
30-May-2014 4:00 PM EDT

see all experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact to configure this module.


The mission of the University of Colorado Cancer Center is to discover, develop and deliver breakthroughs in diagnosis, treatment, and prevention that improve cancer care locally, nationally and globally. These efforts form the basis of a comprehensive spectrum of translational prevention, diagnosis, treatment, survivorship and outreach programs and provide a framework for training the next generation of cancer researchers and physicians.


Erika Matich
Communications Manager


Garth Sundem
Science Writer
Cancer Science



Chat now!